Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
出版年份 2020 全文链接
标题
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-12-07
DOI
10.1038/s41467-020-19957-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men
- (2020) Christian Benedict et al. NEUROLOGY
- Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
- (2020) Chun-Wei Chang et al. Frontiers in Neurology
- Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
- (2020) Barkovits et al. Cells
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies
- (2019) Xue-Ning Shen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma alpha-synuclein detected by single molecule array is increased in PD
- (2019) Adeline S. L. Ng et al. Annals of Clinical and Translational Neurology
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
- (2019) Oskar Hansson et al. Alzheimers Research & Therapy
- Clinical laboratory tests used to aid in the diagnosis of human prion disease
- (2019) Allyson Connor et al. JOURNAL OF CLINICAL MICROBIOLOGY
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis
- (2019) Yinan Zhao et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Towards a unified protocol for handling of CSF before β-amyloid measurements
- (2019) Shorena Janelidze et al. Alzheimers Research & Therapy
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC
- (2019) Samir Abu-Rumeileh et al. JOURNAL OF NEUROLOGY
- Machine learning algorithm validation with a limited sample size
- (2019) Andrius Vabalas et al. PLoS One
- Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
- (2019) Christopher D. Whelan et al. Acta Neuropathologica Communications
- Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
- (2018) Erik Portelius et al. ACTA NEUROPATHOLOGICA
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Neurofilament light: A candidate biomarker of pre-symptomatic ALS and phenoconversion
- (2018) Michael Benatar et al. ANNALS OF NEUROLOGY
- Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
- (2018) Ulf Andreasson et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Memory decline accompanies subthreshold amyloid accumulation
- (2018) Susan M. Landau et al. NEUROLOGY
- The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease
- (2018) Bianca A. Trombetta et al. PLoS One
- A systematic review comparing the diagnostic value of 14-3-3 protein in the cerebrospinal fluid, RT-QuIC and RT-QuIC on nasal brushing in sporadic Creutzfeldt–Jakob disease
- (2018) Olivia Behaeghe et al. ACTA NEUROLOGICA BELGICA
- Candidate Blood Proteome Markers of Alzheimer's Disease Onset and Progression: A Systematic Review and Replication Study
- (2018) Steven J. Kiddle et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid α-Synuclein and Lewy Body-Like Symptoms in Normal Controls, Mild Cognitive Impairment, and Alzheimer's Disease
- (2018) R. Scott Mackin et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts
- (2018) Andrew S. P. Lim et al. PLOS MEDICINE
- Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
- (2018) Leslie M. Shaw et al. Alzheimers & Dementia
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
- (2017) Petra Steinacker et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diurnal oscillation of CSF Aβ and other AD biomarkers
- (2017) Brendan P. Lucey et al. Molecular Neurodegeneration
- YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
- (2017) Franc Llorens et al. Molecular Neurodegeneration
- Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
- (2017) Paolo Eusebi et al. MOVEMENT DISORDERS
- Parallelism experiments to evaluate matrix effects, selectivity and sensitivity in ligand-binding assay method development: pros and cons
- (2017) Jing Tu et al. Bioanalysis
- Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
- (2017) Daniela Bertens et al. Alzheimers Research & Therapy
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Proteome-Based Plasma Markers of Brain Amyloid-β Deposition in Non-Demented Older Individuals
- (2017) Madhav Thambisetty et al. JOURNAL OF ALZHEIMERS DISEASE
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals
- (2016) Ramon Casanova et al. Alzheimers & Dementia
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease
- (2016) Puneet Talwar et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- 1,500 scientists lift the lid on reproducibility
- (2016) Monya Baker NATURE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Validation of serum free light chain reference ranges in primary care
- (2016) Luca Galvani et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET
- (2016) Danielle van Westen et al. Scientific Reports
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
- (2015) Sylvia Villeneuve et al. BRAIN
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
- (2014) Sebastian Palmqvist et al. JAMA Neurology
- Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
- (2013) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease
- (2013) Tao Wang et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
- (2013) S C Burnham et al. MOLECULAR PSYCHIATRY
- Power failure: why small sample size undermines the reliability of neuroscience
- (2013) Katherine S. Button et al. NATURE REVIEWS NEUROSCIENCE
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42
- (2012) Niklas Mattsson et al. Biomarkers in Medicine
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Raise standards for preclinical cancer research
- (2012) C. Glenn Begley et al. NATURE
- Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
- (2012) Maria Björkqvist et al. PLoS One
- Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden
- (2012) Steven John Kiddle et al. PLoS One
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
- (2011) John P. A. Ioannidis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Believe it or not: how much can we rely on published data on potential drug targets?
- (2011) Florian Prinz et al. NATURE REVIEWS DRUG DISCOVERY
- Plasma A and PET PiB binding are inversely related in mild cognitive impairment
- (2011) D. P. Devanand et al. NEUROLOGY
- Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
- (2011) Niklas Mattsson et al. NEUROMOLECULAR MEDICINE
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started